Edgar Parker

Intelgenx Corp. develops oral-controlled release pharmaceutical products. The firm offers pharmaceuticals services to pharmaceutical partners, including R&D, analytical method development, clinical monitoring, IP and regulatory services. The company was founded in 2003 and is headquartered in Saint-Laurent, Canada.

The Bank of Canada provides banking and financial services. Its services include mortgage and payment processing, loan application, credit card application, accounting solutions, tax preparation, financial analysis, insurance, and payroll processing services to its clients. The company was founded in 1934 and is headquartered in Ottawa, Canada.

BDC Venture Capital (BDC Venture Capital) is a venture capital firm founded in 1975. The firm is headquartered in Québec, Canada.

DRI Capital, Inc. (DRI Capital) is a private equity firm, a subsidiary of Persis Holdings Ltd founded in 1992. The firm is headquartered in Toronto, Canada.

Kirchner Private Capital Group provides merchant banking services. It offers mergers, acquisitions, and divestitures advisory; management assessment; and workouts and turnarounds management services. The firm also provides strengths, weaknesses, opportunities, and threats analysis; negotiation; and strategic planning services. The company was founded by W. B. Kirchner in 1985 and is headquartered in Gadsden, AL.

Pillar5 Pharma, Inc. develops, researches and manufactures sterile opthalmic and solid dose. It offers solid dose manufacturing, solid dose packaging, analytical and microbiological testing, and formulation and process development services. The company was founded in 2009 and is headquartered in Arnprior, ON.

Export Development Canada engages in the provision of insurance and financial services. It offers bond products, financing, insurance, and risk management solutions to help Canadian exporters and investors expand their international business. The company was founded in 1944 and is headquartered in Ottawa, Canada.

Novartis Pharmaceuticals Canada, Inc. manufactures chemicals and pharmaceuticals products. It provides solutions on patients suffering from a variety of major illnesses including cancer, cardiovascular diseases, Alzheimer's disease, age-related macular degeneration, organ transplantation, and osteoporosis. The company was founded in 1996 and is headquartered in Dorval, Canada.

Rimon Therapeutics Ltd. develops and markets pharmaceutical products. The company was founded by Michael May and is headquartered in Mississauga, Canada.

Part of Nash Hannem & Associates, Unsworth Kachafanas is a Canadian company that provides accounting services. The company is based in Sydney, Canada. Unsworth Kachafanas was acquired by Nash Hannem & Associates on October 29, 2014.

Part of PharmEng International, Inc., PharmEng Technology, Inc. is a full-service consulting firm that serves pharmaceutical, biotechnology, and medical device industries. The company is based in Toronto, Canada. PharmEng Technology prides itself on its proven track record of excellence which ensures that all client needs and governing regulatory expectations are met and exceeded. Since 1997, the Canadian company has provided industry-recognized services to assist clients in the rapid commercialization of new products from drug discovery to strategic planning to process scale up. The company was founded in 1977 by Alan Kwong. Alan Kwong has been the CEO since 1977.

GLYCODesign, Inc. develops pharmaceutical products. The company engages in the discovery and development of novel therapeutics for life-threatening diseases such as cancer, infectious diseases, inflammation, and cardiovascular diseases. GLYCODesign focuses on inhibiting the enzymes that produce the abnormal carbohydrates. The company was founded by Jeremy Carver in 1993 and is headquartered in Toronto, Canada.

Millenium Biologix Corp. is focused on the development and commercialization of next generation, skeletal tissue regeneration products and implantable medical devices, initially targeted for orthopedic uses. These products, used alone or in combination configurations, promote the repair and natural healing of human bone and other skeletal tissues such as cartilage. Millenium's strength in developing leading treatments for regenerative medicine is based on its successful integration of three core competencies in advanced biomaterials, biologics and engineering. Its core business activities are focused on tissue engineering products, and on orthobiologicals. It was founded on April 1, 1998 and is headquartered in Kingston, ON.

Cita Neuro Pharmaceuticals, Inc. develops and commercializes small molecule drugs. Its clinical drug portfolio consists of drugs for Parkinson's disease and neuropathic pain. Cita Neuro Pharmaceuticals was founded in 1997 by Brian Bennett, Roland Boegman, Khem Jha-mandas, James Reynolds and Gregory Thatcher and is headquartered in Mississauga, Canada.

Trimel Capital Corp. operates as a capital pool firm. It aims to identify and evaluate businesses and assets with a view to completing a qualifying transaction. The company was founded on July 17, 2019 is headquartered in Toronto, Canada.